1. Home
  2. BBAR vs SUPN Comparison

BBAR vs SUPN Comparison

Compare BBAR & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BBAR

Banco BBVA Argentina S.A. ADS

HOLD

Current Price

$14.23

Market Cap

3.1B

Sector

Finance

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$49.60

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBAR
SUPN
Founded
1886
2005
Country
Argentina
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.8B
IPO Year
1997
2010

Fundamental Metrics

Financial Performance
Metric
BBAR
SUPN
Price
$14.23
$49.60
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$17.00
$61.60
AVG Volume (30 Days)
803.5K
530.8K
Earning Date
03-04-2026
05-05-2026
Dividend Yield
1.79%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$392,755,000.00
Revenue This Year
$12.21
$22.72
Revenue Next Year
$13.00
$18.10
P/E Ratio
$26.78
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.76
$29.16
52 Week High
$23.10
$59.68

Technical Indicators

Market Signals
Indicator
BBAR
SUPN
Relative Strength Index (RSI) 44.65 42.81
Support Level $13.13 $47.43
Resistance Level $17.36 $52.14
Average True Range (ATR) 0.82 1.77
MACD 0.21 -0.20
Stochastic Oscillator 53.28 35.23

Price Performance

Historical Comparison
BBAR
SUPN

About BBAR Banco BBVA Argentina S.A. ADS

Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focuses on foreign trade, agricultural business, and digital products.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: